Karl Lintner
36 Papers
407 Citations
Karl Lintner is an academic researcher. The author has contributed to research in topics: Active ingredient & Amino acid. The author has an hindex of 11, co-authored 36 publications.
Chat about Author
Papers
Patent
Cosmetic or dermopharmaceutical composition comprising an euglena extract
Karl Lintner,Chamberlin Claire Mas,Louis Lamy,Philippe Mondon +3 more
- 13 Jan 2006
TL;DR: In this article, a cosmetic or dermopharmaceutic composition containing an Euglena extract, its use to activate the cellular metabolism and in particular to protect and/or improve the state of the skin and to reduce the signs of ageing in particular.
79
Cosmeceuticals and active ingredients
TL;DR: For a product to be successful in the marketplace, the benefits of the product must clearly be communicated to the consumer, and the consumer must be satisfied with product performance.
61
Patent
Topical use of teprenone
Karl Lintner,Chamberlin Claire Mas +1 more
- 12 May 2006
TL;DR: Topical use of teprenone in a cosmetic or dermopharmaceutical composition as an active preventing and/or limiting the skin cells senescence and /or protecting the general state of the skin this article.
50
Patent
Slimming cosmetic compositions
Karl Lintner,Chamberlin Claire Mas +1 more
- 18 Jul 2006
TL;DR: Cosmetic or dermopharmaceutical compositions containing, in a dermatologically acceptable carrier, at least one diterpene among: cafestol, kahweol, and chemical derivatives are useful for slimming treatments including prevent and/or treat cellulite or orange peel and refine contours of the face, skin firming, to reduce the steatomery of the thighs, to decrease the volume/fatty overload of the spare tire at the hips, and to reduce “love handles”, both on men and women as mentioned in this paper.
41
Patent
Formulations and method for treating baldness
Karl Lintner,Claire Mas-Chamberlin +1 more
- 22 Apr 2011
TL;DR: In this article, a novel formulation for the treatment of hair loss comprising oleanolic acid (a 5α-reductase inhibitor), apigenin (a vasodilator), and biotinyl-GHK (a cell metabolism stimulant) was presented.
40